AstraZeneca’s Ultomiris, already approved for the treatment of four rare diseases, has also shown potential in another rare disease, IgA…

WASHINGTON – The Trump administration will ask states to create new plans to verify health care workers paid by federally…

Researchers have developed a powerful new imaging technique that reveals ultrafast phenomena in the microscopic world in far more detail…

After winning two clinical trials for intractable and early-stage kidney cancer, Merck & Co.’s blockbuster candidate Wellireg surprisingly failed to…

People systematically underestimate how often things go wrong in the world. Researchers call this the “failure gap.” This huge project…